Free Trial

CenterBook Partners LP Reduces Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Intuitive Surgical logo with Medical background

CenterBook Partners LP lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 86.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 517 shares of the medical equipment provider's stock after selling 3,196 shares during the period. CenterBook Partners LP's holdings in Intuitive Surgical were worth $270,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of the business. M.E. Allison & CO. Inc. purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $449,000. Seilern Investment Management Ltd bought a new position in shares of Intuitive Surgical during the fourth quarter valued at about $82,517,000. Sycomore Asset Management grew its stake in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock worth $9,214,000 after purchasing an additional 4,079 shares during the last quarter. Exome Asset Management LLC raised its position in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock valued at $3,649,000 after purchasing an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. lifted its holdings in Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after buying an additional 525 shares during the period. Institutional investors own 83.64% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on ISRG shares. CICC Research initiated coverage on Intuitive Surgical in a report on Monday, January 27th. They set a "neutral" rating and a $550.00 target price for the company. Evercore ISI upped their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Leerink Partners lifted their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Raymond James increased their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Finally, Truist Financial cut their price objective on Intuitive Surgical from $666.00 to $605.00 and set a "buy" rating on the stock in a research report on Monday, March 17th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $611.81.

Get Our Latest Research Report on ISRG

Intuitive Surgical Stock Up 0.3 %

Shares of NASDAQ ISRG traded up $1.40 during midday trading on Friday, hitting $482.74. The stock had a trading volume of 1,618,989 shares, compared to its average volume of 1,601,901. The business's 50 day moving average is $524.41 and its 200-day moving average is $532.04. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The company has a market cap of $171.94 billion, a P/E ratio of 75.31, a PEG ratio of 5.85 and a beta of 1.55.

Insider Activity at Intuitive Surgical

In other news, VP Fredrik Widman sold 810 shares of the business's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $464,761.80. Following the completion of the transaction, the vice president now owns 473 shares in the company, valued at $271,397.94. The trade was a 63.13 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Recommended Stories

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Should You Invest $1,000 in Intuitive Surgical Right Now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines